Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Company profile
Latest filings (excl ownership)
DFAN14A
Additional proxy materials by non-management
20 Mar 06
SC TO-T/A
Third party tender offer statement (amended)
27 Jul 05
SC TO-T/A
Third party tender offer statement (amended)
21 Jul 05
SC TO-T/A
Third party tender offer statement (amended)
19 Jul 05
SC TO-T/A
Third party tender offer statement (amended)
8 Jul 05
SC TO-T/A
Third party tender offer statement (amended)
5 Jul 05
SC TO-T/A
Third party tender offer statement (amended)
21 Jun 05
SC TO-T/A
Third party tender offer statement (amended)
15 Jun 05
SC TO-T/A
Third party tender offer statement (amended)
7 Jun 05
SC TO-T/A
Third party tender offer statement (amended)
2 Jun 05
Latest ownership filings
No filings